PLACENTAL PROTEIN 5: DISAPPEARANCE FROM THE CIRCULATION AFTER DELIVERYOBIEKWE BC; SOOBY J; SALEM HT et al.1982; EUR. J. OBSTET. GYNECOL. REPROD. BIOL.; ISSN 0301-2115; NLD; DA. 1982; VOL. 13; NO 1; PP. 1-5; BIBL. 12 REF.Article

STUDY ON THE BIOLOGICAL HALF-LIFE AND ORGAN-DISTRIBUTION OF TRITIATED LYSINE-VASOPRESSIN IN BRATTLEBORO RATSLACZI F; LASZLO FA; KERI G et al.1980; ACTA PHYSIOL. ACAD. SCI. HUNG.; ISSN 0001-6756; HUN; DA. 1980; VOL. 55; NO 2; PP. 129-133; ABS. RUS; BIBL. 15 REF.Article

FUNCTIONAL M RNA HALF LIVES IN E. COLIPEDERSEN S; REEH S; FRIESEN JD et al.1978; MOLEC. GEN. GENET.; DEU; DA. 1978; VOL. 166; NO 3; PP. 329-336; BIBL. 30 REF.Article

SOMATOSTATIN HALF-LIFE: A CASE REPORT IN ONE HEALTHY VOLUNTEER AND A THREE MONTH FOLLOW-UPBETHGE N; DIEL F; ROSICK M et al.1981; HORM. METAB. RES.; ISSN 0018-5043; DEU; DA. 1981; VOL. 13; NO 12; PP. 709-710; BIBL. 6 REF.Article

FURTHER OBSERVATIONS ON RELATIONSHIPS BETWEEN ANTIPYRINE HALF-LIFE-CLEARANCE AND VOLUME OF DISTRIBUTION: AN APPRAISAL OF ALTERNATIVE KINETIC PARAMETERS USED TO ASSESS THE ELIMINATION OF ANTIPYRINESULTATOS LG; DVORCHIK BH; VESELL ES et al.1980; CLIN. PHARMACOKINET; NLD; DA. 1980; VOL. 5; NO 3; PP. 263-273; BIBL. 2 P.Article

DIE WIRKUNGSGERECHTE ANWENDUNG VON ALLOPURINOL IN DER LANGZEITBEHANDLUNG = L'EMPLOI DE L'ALLOPURINOL A ACTION CALCULEE PENDANT LE TRAITEMENT PROLONGEFENNER H.1980; FORTSCHR. D. MED.; DEU; DA. 1980; VOL. 98; NO 10; PP. 373-376; BIBL. 10 REF.Article

EFFECT OF PLASMA PROTEIN AND TISSUE BINDING ON THE BIOLOGIC HALF-LIFE OF DRUGSGIBALDI M; LEVY G; MCNAMARA PJ et al.1978; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1978; VOL. 24; NO 1; PP. 1-4; BIBL. 16 REF.Article

METABOLIC CLEARANCE AND PLASMA HOLF-DISAPPEARANCE TIME OF EXOGENOUS SOMATOSTATIN IN MANSHEPPARD M; SHAPIRO B; PIMSTONE B et al.1979; J. CLIN. ENDOCRINOL. METABOL.; USA; DA. 1979; VOL. 48; NO 1; PP. 50-53; BIBL. 20 REF.Article

THE HALF-LIFE OF MRNA IN SACCHAROMYCES CEREVISIAE.LI LI CHIA; MCLAUGHLIN C.1979; MOLEC. GEN. GENET.; DEU; DA. 1979; VOL. 170; NO 2; PP. 137-144; BIBL. 20 REF.Article

ZUR EFFEKTIVEN HALBWERTZEIT BEI DER RADIOJODTHERAPIE DER SCHILDDRUESE. = TEMPS DE DEMI-VIE EFFICACE DANS LE TRAITEMENT PAR IODE RADIOACTIF DES AFFECTIONS THYROIDIENNESHLISCS R; HENNIG K.1977; DTSCHE GESUNDH.-WES.; DTSCH.; DA. 1977; VOL. 32; NO 49; PP. 2336-2339; ABS. RUSSE ANGL.; BIBL. 3 REF.Article

MEASUREMENT OF HALF-LIFE OF HUMAN PLASMA FIBRINOGEN.STEIN TP; LESKIW MJ; WALLACE HW et al.1978; AMER. J. PHYSIOL., ENDOCRINOL. METABOL. GASTROINTESTIN. PHYSIOL.; USA; DA. 1978; VOL. 3; NO 5; PP. 504-510; BIBL. 43 REF.Article

HALF LIFE OF INJECTED ¹²⁵I-INSULIN IN CONTROL AND OB/OB MICE.CRESTO JC; LAVINE RL; BUCHLY ML et al.1977; ACTA PHYSIOL. LATINO AMER.; ARGENT.; DA. 1977; VOL. 27; NO 1; PP. 11-19; BIBL. 22 REF.Article

The Operational Multiple Dosing Half-life : A Key to Defining Drug Accumulation in Patients and to Designing Extended Release Dosage FormsSAHIN, Selma; BENET, Leslie Z.Pharmaceutical research. 2008, Vol 25, Num 12, pp 2869-2877, issn 0724-8741, 9 p.Article

FATE OF HUMAN CORTICOTROPHIN IMMEDIATELY AFTER INTRAVENOUS ADMINISTRATION TO THE RATAMBLER L; BENNETT HPJ; HUDSON AM et al.1982; J. ENDOCRINOL.; ISSN 0022-0795; GBR; DA. 1982; VOL. 93; NO 2; PP. 287-292; BIBL. 9 REF.Article

PHARMACOKINETICS OF VILOXAZINE HYDROCHLORID IN MANVANDEL B; VANDEL S; JOHNET JM et al.1982; EUR. J. DRUG METAB. PHARMACOKINET.; ISSN 0378-7966; CHE; DA. 1982; VOL. 7; NO 1; PP. 65-68; BIBL. 11 REF.Article

A POCKET CALCULATOR PROGRAM TO FIT FIRST ORDER KINETIC CURVESOSBORNE MR.1982; COMPUT. BIOL. & MED.; ISSN 0010-4825; GBR; DA. 1982; VOL. 12; NO 2; PP. 159-162; BIBL. 3 REF.Article

INSULIN HALF-LIFE IN MAN AFTER TRAUMAMEGUID MM; AUN F; SOELDNER JS et al.1981; SURGERY; ISSN 0039-6060; USA; DA. 1981; VOL. 89; NO 6; PP. 650-653; BIBL. 21 REF.Article

LITHIUM ELIMINATION HALF-LIFE AND DURATION OF THERAPYGOODNICK PJ; FIEVE RR; MELTZER HL et al.1981; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1981; VOL. 29; NO 1; PP. 47-50; BIBL. 27 REF.Article

KLINISCHE PHARMAKOKINETIK VON MIDAZOLAM, FLUNITRAZEPAM UND DIAZEPAM = PHARMACOCINETIQUE CLINIQUE DU MIDAZOLAM, FLUNITRAZEPAM ET DIAZEPAMLAUVEN PM; STOECKEL H; SCHWILDEN H et al.1981; ANAESTH., INTENSIVTHER. NOTFALLMED.; ISSN 0174-1837; DEU; DA. 1981; VOL. 16; NO 3; PP. 135-142; ABS. ENG; BIBL. 17 REF.Article

ABSORPTION EFFICIENCY AND BIOLOGICAL HALF-LIFE OF INDIVIDUAL CHLOROBIPHENYLS IN RATS TREATED WITH KANECHLOR PRODUCTSTANABE S; NAKAGAWA Y; TATSUKAWA R et al.1981; AGRIC. BIOL. CHEM.; ISSN 0002-1369; JPN; DA. 1981; VOL. 45; NO 3; PP. 717-726; BIBL. 35 REF.Article

ACCEPTABLE SAMPLING TIMES AT PLATEAU FOR DRUG ANALYSISROWLAND M; UNADKAT JD.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 12; NO 5; PP. 687-689; BIBL. 2 REF.Article

ALTERATION OF THEOPHYLLINE CLEARANCE AND HALF-LIFE BY CIMETIDINE IN NORMAL VOLUNTEERSREITBERG DP; BERNHARD DH; SCHENTAG JJ et al.1981; ANN. INTERN. MED.; ISSN 0003-4819; USA; DA. 1981; VOL. 95; NO 5; PP. 582-585; BIBL. 15 REF.Article

ANTIPYRINE PHARMACOKINETICS IN THE PREGNANT RATDEAVY M; O'DONNELL L; PENGLIS S et al.1980; DRUG METAB. DISPOS.; USA; DA. 1980; VOL. 8; NO 4; PP. 265-267; BIBL. 15 REF.Article

MAGNESIUM METABOLISM IN BLOOD AND THE WHOLE BODY IN MAN USING ²⁸ MAGNESIUMWATSON WS; HILDITCH TE; HORTON PW et al.1979; METABOLISM; USA; DA. 1979; VOL. 28; NO 1; PP. 90-95; BIBL. 23 REF.Article

THE BIOLOGIC HALF-LIFE OF HEPARINMCAVOY TJ.1979; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1979; VOL. 25; NO 3; PP. 372-379; BIBL. 18 REF.Article